Prasad S. Adusumilli
Papers
19
Total Citations
1,322
H-Index
14
About
Prasad S. Adusumilli is a prominent thoracic surgeon and researcher whose work has fundamentally shaped minimally invasive and robotic-assisted approaches to thoracic oncology. Based at a leading academic institution, his research spans two critical domains: lung cancer surgery and esophageal cancer management, with a particular focus on optimizing surgical technique, patient outcomes, and quality of life. Adusumilli has made landmark contributions to the comparative analysis of surgical approaches for non-small cell lung cancer (NSCLC). His 2016 study on lobectomy outcomes—now cited over 333 times—provided the first meaningful survival comparisons between robotic, VATS, and open approaches for stage I NSCLC, influencing surgical decision-making worldwide. His 2018 investigation into neoadjuvant nivolumab immunotherapy before resection (299 citations) helped establish the foundation for modern neoadjuvant immunotherapy protocols in resectable lung cancer. In esophageal surgery, he has been a pioneering force in robotic-assisted minimally invasive esophagectomy (RAMIE), carefully documenting the learning curve, safety profile, and quality-of-life benefits of this complex procedure across multiple landmark studies. His work on near-infrared fluorescence imaging further exemplifies his commitment to surgical innovation. Collectively, his research has profoundly influenced how thoracic surgeons approach cancer resection globally.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10